Aerie Pharmaceuticals (NASDAQ:AERI)‘s stock had its “buy” rating restated by stock analysts at Mizuho in a research note issued to investors on Friday, AnalystRatings.com reports. Several other analysts have also recently issued reports on the company. Guggenheim assumed coverage on Aerie Pharmaceuticals in a research note on Tuesday, September 8th. They set a “buy” rating […]
